	Effective inhibition of lung metastatic melanoma by pH-responsive lipopeptide/PLGA hybrid nanoparticles silencing PD-L1 with augmented suppression of the AKT/Î²-catenin pathway. J Mater Chem B Yang Z, Wang S, Song Z, Guo R, Ding D, Gao Y, Qiao M. PMID: 41709848 [PubMed - as supplied by publisher]
	Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? Br J Cancer Woodford R, Lorigan P, Oudit D, Abdulgawad A, Thistlethwaite F, Lim KHJ. PMID: 41708938 [PubMed - as supplied by publisher]
	Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635. Clin Transl Sci Gontier G, Kim G, Wang C, Zhu K, Gau R, Zhang N, Naphade S, Stewart A, Schmidt MJ, Galemmo R, Shook B, Tarachandani A, Choi I, Raines S, Scannevin RH, Grievink HW, Smits LMG, Kremer PHC, Cadavid D. PMID: 41708347 [PubMed - indexed for MEDLINE]
	Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study. J Am Acad Dermatol Driscoll CB, Schwab G, Quan VL, McKenney J, Hooper MJ, Shankar Ramesh Kumar SK, Kundu RV, Kundu SD. PMID: 41707711 [PubMed - as supplied by publisher]
	Integrated LIBS-Raman spectroscopy coupled with explainable machine learning for biochemical characterization of melanoma. Spectrochim Acta A Mol Biomol Spectrosc Khan MN, Zhou Q, Guo J, Liu L, Hu R. PMID: 41707627 [PubMed - as supplied by publisher]
	[Utilization and diagnostic yield of the Fast-Track Referral Pathway for suspected melanoma: a six-year analysis]. Semergen Alonso-Chornet V, Armengot-Carbó M. PMID: 41707403 [PubMed - as supplied by publisher]
	Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion. Proc Natl Acad Sci U S A Baird MA, Jewett CE, Malide DA, Kratz L, Cartagena-Rivera AX, Fischer RS, Waterman CM. PMID: 41706894 [PubMed - indexed for MEDLINE]
	Mucosal Melanoma of Head and Neck: A Rare and Aggressive Disease-A Register-Based Cohort Study. J Oral Pathol Med Degerholm SC, Salo TA, Mauramo MO. PMID: 41704147 [PubMed - as supplied by publisher]
	Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings. Curr Opin Oncol Boussingault L, Mtimet L, Suppa M. PMID: 41703997 [PubMed - indexed for MEDLINE]
	Melanoma in adolescents and young adults: special considerations. Curr Opin Oncol Abboud S, Romano L, Langouo Fontsa M. PMID: 41703996 [PubMed - indexed for MEDLINE]
	Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China. Acta Derm Venereol Li S, Zou J, Chen R, Zhang L. PMID: 41703988 [PubMed - indexed for MEDLINE]
	Insurance, race, and socioeconomic disparities in systemic therapy receipt for melanoma in the United States: a systematic review. Melanoma Manag Zhang S, Hernandez RK, Cheek J, Aziz R, Vetter IL, Adamson AS. PMID: 41703897 [PubMed]
	I was the barrier: A patient's perspective on delayed diagnosis of malignant melanoma. Clin Exp Dermatol Hoban J, Leahy M, Byrne B, Lynch M, McKeown P. PMID: 41703785 [PubMed - as supplied by publisher]
	A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma. Cancer Zakharia Y, Kim D, Freesmeier M, Frees M, Mott S, Monga V, Laux D, Javed A, Rieth J, Smestad J, Milhem M. PMID: 41701511 [PubMed - indexed for MEDLINE]
	Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open Leachman SA, Luke JJ, Ascierto PA, Long GV, Khattak MA, Rutkowski P, Xu ZJ, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Schadendorf D. PMID: 41701495 [PubMed - indexed for MEDLINE]
	Verhoeff-van Gieson May Distinguish Desmoplastic Melanoma From Re-Excision Scar. Am J Dermatopathol Kiszluk A, Alhalaseh YN, Asar MC, Chen F, Speiser JJ. PMID: 41700577 [PubMed - indexed for MEDLINE]
	LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial. Nat Commun Hamid O, Ekström-Rydén V, Mehmi I, Wang D, Patel M, Alsaqal S, Irenaeus S, Nordström C, Sandin LC, Grauers Wiktorin H, Lövgren T, Eriksson E, Leja-Jarblad J, Loskog A, Ullenhag GJ. PMID: 41698954 [PubMed - indexed for MEDLINE]
	Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study. Lancet Oncol Dummer R, Guo J, Luke JJ, Carlino MS, Schadendorf D, Khattak MA, Hauschild A, Ascierto PA, Chen Y, Shin SJ, Rutkowski P, Luo Z, Chen J, Rivalland G, Coetzee C, Ribas A, Mujika K, Markel G, Villarroel RU, Dizdar O, Caglevic C, Grebennik D, Donovan K, Krepler C, Long GV. PMID: 41698381 [PubMed - as supplied by publisher]
	Modern Management of Newly Diagnosed Vulvovaginal Melanoma. J Natl Compr Canc Netw Leitao MM Jr. PMID: 41698346 [PubMed - as supplied by publisher]
	Non-coding RNA transcripts and their exosomal counterparts in the pathogenesis, diagnosis, and treatment of skin cancers, with a focus on melanoma. Front Mol Biosci Zou L, Wen X, Dai X, Wu Y. PMID: 41696579 [PubMed]

Articles 1 - 20 / 45167

Page 1 of 2259



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy